{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:27Z","timestamp":1792406487496,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","award":["2022QNA068"],"award-info":[{"award-number":["2022QNA068"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103072","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:27:55Z","timestamp":1791937675000},"page":"103072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NR3C2 suppresses triple-negative breast cancer progression by regulating mitochondrial ROS homeostasis via NDUFB3"],"prefix":"10.1016","volume":"74","author":[{"given":"Haihong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaonan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103072_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103072_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.tranon.2026.103072_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2026.103072_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167880","article-title":"Angiogenesis and immune microenvironment in triple-negative breast cancer: targeted therapy","volume":"1871","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"key":"10.1016\/j.tranon.2026.103072_bib0005","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with Pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0006","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.103072_bib0007","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0009","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1089\/dna.2020.5771","article-title":"lncRNA HOTAIR promotes DNA repair and radioresistance of breast cancer via EZH2","volume":"39","author":"Qian","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.103072_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103072_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103072_bib0014","doi-asserted-by":"crossref","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","article-title":"Mitochondria-targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer","volume":"18","author":"Lu","year":"2024","journal-title":"ACS. Nano"},{"key":"10.1016\/j.tranon.2026.103072_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155761","article-title":"Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming","volume":"152","author":"Ji","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.tranon.2026.103072_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.tranon.2026.103072_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213880","article-title":"Mitochondrial Respiratory chain supercomplexes: from structure to function","volume":"23","author":"Guan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103072_bib0018","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","article-title":"Mitochondrial complex I","volume":"82","author":"Hirst","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tranon.2026.103072_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262010240","article-title":"Reactive oxygen species across death pathways: gatekeepers of apoptosis, ferroptosis, pyroptosis, paraptosis, and beyond","volume":"26","author":"Sendtner","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103072_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1871520621666210608095512","article-title":"Reactive oxygen species (ROS): key components in cancer therapies","volume":"22","author":"Sahoo","year":"2022","journal-title":"AntiCancer Agents Med. Chem."},{"key":"10.1016\/j.tranon.2026.103072_bib0021","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","article-title":"Reactive oxygen species and DNA damage response in cancer","volume":"364","author":"Renaudin","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119942","article-title":"Reactive oxygen species: role in carcinogenesis, cancer cell signaling and tumor progression","volume":"284","author":"Sarmiento-Salinas","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.tranon.2026.103072_bib0023","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.celrep.2018.06.072","article-title":"ULK1 Phosphorylates and regulates mineralocorticoid receptor","volume":"24","author":"Shibata","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.103072_bib0024","doi-asserted-by":"crossref","DOI":"10.1080\/08916934.2023.2189135","article-title":"NR3C2 mediates oxidised low-density lipoprotein-induced human coronary endothelial cells dysfunction via modulation of NLRP3 inflammasome activation","volume":"56","author":"Chen","year":"2023","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tranon.2026.103072_bib0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00395-024-01032-6","article-title":"Mineralocorticoid receptor promotes cardiac macrophage inflammaging","volume":"119","author":"Fraccarollo","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.tranon.2026.103072_bib0026","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12964-024-01991-2","article-title":"Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism","volume":"22","author":"Mohib","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.tranon.2026.103072_bib0027","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/jcmm.17706","article-title":"NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK","volume":"27","author":"Liu","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0028","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41419-025-07575-3","article-title":"The NR3C2-SIRT1 signaling axis promotes autophagy and inhibits epithelial mesenchymal transition in colorectal cancer","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.103072_bib0029","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/mmr.2022.12649","article-title":"NR3C2 suppresses the proliferation, migration, invasion and angiogenesis of colon cancer cells by inhibiting the AKT\/ERK signaling pathway","volume":"25","author":"Li","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tranon.2026.103072_bib0030","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1096\/fj.201801151R","article-title":"MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma","volume":"33","author":"Yang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tranon.2026.103072_bib0031","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.27940","article-title":"Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma","volume":"62","author":"Nie","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2026.103072_bib0032","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/carcin\/bgae025","article-title":"MIF\/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways","volume":"45","author":"Yang","year":"2024","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tranon.2026.103072_bib0033","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.074","article-title":"miR-135b-5p promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.tranon.2026.103072_bib0034","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1158\/0008-5472.CAN-15-2841","article-title":"A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.103072_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102926","article-title":"Mitochondrial complex I ROS production and redox signaling in hypoxia","volume":"67","author":"Okoye","year":"2023","journal-title":"Redox. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0036","article-title":"Targeting mitochondrial complex I of CD177+ neutrophils alleviates lung ischemia-reperfusion injury","volume":"6","author":"Wu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0037","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.ads8738","article-title":"In-cell architecture of the mitochondrial respiratory chain","volume":"387","author":"Waltz","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.tranon.2026.103072_bib0038","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma","volume":"74","author":"Raggi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tranon.2026.103072_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/243876","article-title":"Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death","volume":"2013","author":"Palorini","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1074\/mcp.RA119.001808","article-title":"Mitochondrial oxidative phosphorylation complex regulates NLRP3 inflammasome activation and predicts patient survival in nasopharyngeal carcinoma","volume":"19","author":"Chung","year":"2020","journal-title":"Mol Cell Proteom."},{"key":"10.1016\/j.tranon.2026.103072_bib0041","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.tranon.2026.103072_bib0042","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/metabo16010060","article-title":"Redox vulnerabilities in triple-negative breast cancer: integrative perspectives and emerging therapeutic strategies","volume":"16","author":"Mitochondrial","year":"2026","journal-title":"Metabolites"},{"key":"10.1016\/j.tranon.2026.103072_bib0043","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13046-023-02928-2","article-title":"RGCC-mediated PLK1 activity drives breast cancer lung metastasis by phosphorylating AMPK\u03b12 to activate oxidative phosphorylation and fatty acid oxidation","volume":"42","author":"Cheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103072_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102304","article-title":"Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy","volume":"52","author":"Jiang","year":"2022","journal-title":"Redox. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10549-023-06982-4","article-title":"LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis","volume":"200","author":"Qian","year":"2023","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2026.103072_bib0046","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s11010-022-04449-6","article-title":"Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer","volume":"477","author":"Li","year":"2022","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.tranon.2026.103072_bib0047","doi-asserted-by":"crossref","first-page":"195","DOI":"10.21037\/hbsn.2016.03.07","article-title":"Hormonal control of the metabolic machinery of hepatocellular carcinoma","volume":"5","author":"Cc","year":"2016","journal-title":"Hepatobiliar. Surg. Nutr."},{"key":"10.1016\/j.tranon.2026.103072_bib0048","doi-asserted-by":"crossref","first-page":"696","DOI":"10.62347\/MNYA9065","article-title":"Mineralocorticoid receptor signaling inhibits bladder cancer progression","volume":"14","author":"Nagata","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103072_bib0049","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/en.2018-00831","article-title":"Deciphering steroid receptor crosstalk in hormone-driven cancers","volume":"159","author":"Truong","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.tranon.2026.103072_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106541","article-title":"The multifaceted role of the mineralocorticoid receptor in cancers","volume":"242","author":"Doan","year":"2024","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102946","article-title":"Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K\/Akt\/eNOS signaling pathway in diabetic tubulopathy","volume":"68","author":"Yao","year":"2023","journal-title":"Redox. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0052","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqag055","article-title":"Mineralocorticoid and glucocorticoid receptor cooperation drives advanced phenotypes in triple-negative breast cancer","volume":"167","author":"Posani","year":"2026","journal-title":"Endocrinology"},{"key":"10.1016\/j.tranon.2026.103072_bib0053","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000395","article-title":"Hepatocellular carcinoma cells downregulate NADH:ubiquinone oxidoreductase subunit B3 to maintain reactive oxygen species homeostasis","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tranon.2026.103072_bib0054","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70006","article-title":"Comprehensive analysis of NADH:ubiquinone oxidoreductase subunit B3 in gynecological tumors and identification of its natural inhibitor wedelolactone","volume":"104","author":"Li","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tranon.2026.103072_bib0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003310","article-title":"Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing","volume":"4","author":"Calvo","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tranon.2026.103072_bib0056","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41586-022-04979-5","article-title":"Oocytes maintain ROS-free mitochondrial metabolism by suppressing complex I","volume":"607","author":"Rodr\u00edguez-Nuevo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103072_bib0057","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11427-025-3075-7","article-title":"Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancer","volume":"69","author":"Liao","year":"2026","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.tranon.2026.103072_bib0058","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.3390\/ijms25136939","article-title":"Mitochondrial elongation and ROS-mediated apoptosis in prostate cancer cells under therapy with apalutamide and complex I inhibitor","volume":"25","author":"Baumgartner","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103072_bib0059","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.103072_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tranon.2026.103072_bib0061","doi-asserted-by":"crossref","first-page":"C1431","DOI":"10.1152\/ajpcell.00508.2023","article-title":"Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits","volume":"325","author":"Gnocchi","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tranon.2026.103072_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114127","article-title":"CCL19-armed recombinant influenza virus inhibited colorectal cancer growth by remodeling tumor microenvironment","volume":"28","author":"Ou","year":"2025","journal-title":"iScience"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:50:59Z","timestamp":1792403459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":62,"alternative-id":["S1936523326004080"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103072","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NR3C2 suppresses triple-negative breast cancer progression by regulating mitochondrial ROS homeostasis via NDUFB3","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103072"}}